| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011 | 3031 | 2011 |
| Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ... New England Journal of Medicine 367 (12), 1098-1107, 2012 | 2089 | 2012 |
| Rate of pregnancy-related relapse in multiple sclerosis C Confavreux, M Hutchinson, MM Hours, P Cortinovis-Tourniaire, ... New England Journal of Medicine 339 (5), 285-291, 1998 | 1989 | 1998 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1361 | 2013 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 988 | 2019 |
| Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial C Confavreux, P O'Connor, G Comi, MS Freedman, AE Miller, TP Olsson, ... The Lancet Neurology 13 (3), 247-256, 2014 | 693 | 2014 |
| Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F‐fluorodeoxyglucose positron emission … U Roelcke, L Kappos, J Lechner-Scott, H Brunnschweiler, S Huber, ... Neurology 48 (6), 1566-1571, 1997 | 632 | 1997 |
| Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 Data analysis: Bahlo Melanie 2 Brown Matthew A 6 7 Browning Brian L 20 ... Nature genetics 41 (7), 824-828, 2009 | 545 | 2009 |
| Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination S Ramanathan, S Mohammad, E Tantsis, TK Nguyen, V Merheb, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (2), 127-137, 2018 | 543 | 2018 |
| Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ... Jama 321 (2), 175-187, 2019 | 513 | 2019 |
| Defining secondary progressive multiple sclerosis J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ... Brain 139 (9), 2395-2405, 2016 | 434 | 2016 |
| MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood MB Cox, MJ Cairns, KS Gandhi, AP Carroll, S Moscovis, GJ Stewart, ... PloS one 5 (8), e12132, 2010 | 305 | 2010 |
| Geographical variations in sex ratio trends over time in multiple sclerosis M Trojano, G Lucchese, G Graziano, BV Taylor, S Simpson Jr, V Lepore, ... PloS one 7 (10), e48078, 2012 | 276 | 2012 |
| Computer assisted retraining of attentional impairments in patients with multiple sclerosis AM Plohmann, L Kappos, W Ammann, A Thordai, A Wittwer, S Huber, ... Journal of Neurology, Neurosurgery & Psychiatry 64 (4), 455-462, 1998 | 252 | 1998 |
| Defining reliable disability outcomes in multiple sclerosis T Kalincik, G Cutter, T Spelman, V Jokubaitis, E Havrdova, D Horakova, ... Brain 138 (11), 3287-3298, 2015 | 218 | 2015 |
| Predictors and dynamics of postpartum relapses in women with multiple sclerosis SE Hughes, T Spelman, OM Gray, C Boz, M Trojano, A Lugaresi, ... Multiple Sclerosis Journal 20 (6), 739-746, 2014 | 218 | 2014 |
| Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis VG Jokubaitis, T Spelman, T Kalincik, J Lorscheider, E Havrdova, ... Annals of neurology 80 (1), 89-100, 2016 | 217 | 2016 |
| Sex as a determinant of relapse incidence and progressive course of multiple sclerosis T Kalincik, V Vivek, V Jokubaitis, J Lechner-Scott, M Trojano, G Izquierdo, ... Brain 136 (12), 3609-3617, 2013 | 210 | 2013 |
| The COVID-19 pandemic and the use of MS disease-modifying therapies G Giovannoni, C Hawkes, J Lechner-Scott, M Levy, E Waubant, J Gold Multiple sclerosis and related disorders 39, 2020 | 207 | 2020 |
| Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS KA Ribbons, P McElduff, C Boz, M Trojano, G Izquierdo, P Duquette, ... PloS one 10 (6), e0122686, 2015 | 203 | 2015 |
